These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Requirement of a dynein light chain in TGFbeta/Smad3 signaling. Jin Q, Gao G, Mulder KM. J Cell Physiol; 2009 Dec 31; 221(3):707-15. PubMed ID: 19711352 [Abstract] [Full Text] [Related]
9. Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression. Samarakoon R, Chitnis SS, Higgins SP, Higgins CE, Krepinsky JC, Higgins PJ. PLoS One; 2011 Dec 31; 6(7):e22896. PubMed ID: 21829547 [Abstract] [Full Text] [Related]
10. Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis. Anders RA, Doré JJ, Arline SL, Garamszegi N, Leof EB. J Biol Chem; 1998 Sep 04; 273(36):23118-25. PubMed ID: 9722540 [Abstract] [Full Text] [Related]
11. Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor. Schiller HB, Szekeres A, Binder BR, Stockinger H, Leksa V. Mol Biol Cell; 2009 Feb 04; 20(3):745-56. PubMed ID: 19037107 [Abstract] [Full Text] [Related]
14. Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice. Denton CP, Zheng B, Evans LA, Shi-wen X, Ong VH, Fisher I, Lazaridis K, Abraham DJ, Black CM, de Crombrugghe B. J Biol Chem; 2003 Jul 04; 278(27):25109-19. PubMed ID: 12707256 [Abstract] [Full Text] [Related]